Elevance Health Files 8-K on Financials
Ticker: ELV · Form: 8-K · Filed: Oct 21, 2025 · CIK: 1156039
Sentiment: neutral
Topics: financial-reporting, 8-k
Related Tickers: ELV
TL;DR
ELEVANCE HEALTH (ELV) FILED AN 8-K ON 10/21/25 DETAILING FINANCIALS.
AI Summary
Elevance Health, Inc. filed an 8-K on October 21, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits related to the company's performance. Elevance Health, formerly known as Anthem, Inc., is incorporated in Indiana and headquartered in Indianapolis.
Why It Matters
This filing provides investors with crucial updates on Elevance Health's financial performance and operational results, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine filing of financial information and does not indicate any unusual risks.
Key Players & Entities
- Elevance Health, Inc. (company) — Registrant
- Anthem, Inc. (company) — Former company name
- Indiana (location) — State of incorporation
- Indianapolis (location) — City of principal executive offices
- October 21, 2025 (date) — Date of report
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Elevance Health, Inc.'s Results of Operations and Financial Condition, and to include Financial Statements and Exhibits.
When was this 8-K report filed?
This 8-K report was filed as of October 21, 2025.
What is Elevance Health, Inc.'s former name?
Elevance Health, Inc.'s former name was Anthem, Inc.
Where is Elevance Health, Inc. headquartered?
Elevance Health, Inc. is headquartered at 220 Virginia Ave, Indianapolis, IN 46204.
What is the Commission File Number for Elevance Health, Inc.?
The Commission File Number for Elevance Health, Inc. is 001-16751.
Filing Stats: 1,223 words · 5 min read · ~4 pages · Grade level 15.7 · Accepted 2025-10-21 06:01:35
Key Financial Figures
- $0.01 — ich registered Common Stock, Par Value $0.01 ELV NYSE Indicate by check mark wh
Filing Documents
- d270615d8k.htm (8-K) — 28KB
- d270615dex991.htm (EX-99.1) — 490KB
- g270615g1021034954907.jpg (GRAPHIC) — 6KB
- g270615g1021034955266.jpg (GRAPHIC) — 6KB
- g270615g1021034955407.jpg (GRAPHIC) — 5KB
- g270615g1021034955563.jpg (GRAPHIC) — 4KB
- g270615g1021034955719.jpg (GRAPHIC) — 4KB
- 0001193125-25-244191.txt ( ) — 698KB
- elv-20251021.xsd (EX-101.SCH) — 3KB
- elv-20251021_lab.xml (EX-101.LAB) — 17KB
- elv-20251021_pre.xml (EX-101.PRE) — 11KB
- d270615d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Exhibit 99.1 Press Release, dated October 21, 2025, reporting Elevance Health, Inc. financial results for the quarter ended September 30, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
FORWARD-LOOKING STATEMENTS
FORWARD-LOOKING STATEMENTS This document contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect our views about future events and financial performance and are generally not historical facts. Words such as "expect," "feel," "believe," "will," "may," "should," "anticipate," "intend," "estimate," "project," "forecast," "plan" and similar expressions are intended to identify forward-looking statements. These statements include, but are not limited to: financial projections and estimates and their underlying assumptions; statements regarding plans, objectives and expectations with respect to future operations, products and services; and statements regarding future performance. Such statements are subject to certain risks and uncertainties, many of which are difficult to predict and generally beyond our control, that could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof. You are also urged to carefully review and consider the various risks and other disclosures discussed in our reports filed with the U.S. Securities and Exchange Commission from time to time, which attempt to advise interested parties of the factors that affect our business. Except to the extent required by law, we do not update or revise any forward-looking statements to reflect events or circumstances occurring after the date hereof. These risks and uncertainties include, but are not limited to: trends in healthcare costs and utilization rates; reduced enrollment; our ability to secure and implement sufficient premium rates; the impact of large scale medical emergencies, such as public health epidemics and pandemics, and other catastrophes; the impact of new or changes in existing federal, state and internat